Description:

Kelly H. Zou, PhD, PStat®, FASA

Vice President and Head of Medical Analytics and Insights
Medical Analytics and Insights
R&D and Medical
Upjohn Division

Presentation Title:

Harnessing Real-World Data for Regulatory Use and Applying Innovative Applications 

Abstract:

A vast quantity of real-world data (RWD) are available to healthcare researchers. Such data come from diverse sources such as electronic health records, insurance claims and billing activity, product and disease registries, medical devices used in the home, and applications on mobile devices. The analysis of RWD produces real-world evidence (RWE), which is clinical evidence that provides information about usage and potential benefits or risks of a drug. This presentation focuses on how regulatory authorities are using RWE. The main challenges in harnessing RWD include collating and analyzing numerous disparate types or categories of available information including both structured and unstructured data. Although the use of artificial intelligence to capture, amalgamate, standardize, and analyze RWD is still evolving, it has the potential to support the increased use of RWE to improve healthcare.

For Zoom link please contact Lucia Ontiveros: lucia.ontiveros@northwestern.edu